Arkolith/Insider Trading/NVCT/Form 4

Carson Michael J.

Vice President, FinanceNuvectis Pharma, Inc. (NVCT) · full profile →Form 4 · filed Nov 8, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$22K
Net Open-Market Flow
-$22K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 7, 2024Sell(S)3K$8.16$22K88K
Jan 4, 2024Grant(A)35K—$091K
Jan 3, 2023Grant(A)29K—$056K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-115837) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML